Axess Medica’s eye clinics have been acquired by Aleris AB
October 2014 — Transmedica A/S, based in Denmark, has sold Axess Medica’s eye clinics to Aleris AB for an undisclosed consideration.
Axess Medica’s eye clinics business is called Axess Medica Ögon in Sweden and has clinics located in Helsingborg, Kristianstad and Malmö.
Aleris AB, a healthcare group in Sweden, Norway and Denmark, offers a broad range of medical, surgical and psychiatric healthcare of high quality via its hospitals, specialist clinics, primary care and elderly care units.
Transmedica A/S, based in Denmark and majority-owned by Odin Equity Partners, is a professional healthcare provider, which offers a broad range of services in the Scandinavian healthcare sector.
Our role in the transaction
Oaklins’ teams in Sweden and Denmark advised the seller in this transaction.
Prata med transaktionsteamet
Relaterade transaktioner
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Lär dig merKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Lär dig merGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Lär dig mer